UMAC Unusual Machines, Inc. Insider Trading

UMAC President Camden sells 100,000 shares (28.8% of holdings) for $3.0M at $30.05; stock now $26.39 after 90-day +60.4% rally

Andrew Ross Camden, as President, executed a substantial sale of 100,000 shares at $30.05 on 2026-06-04, reducing his stake from 346,750 to 246,750 shares. The transaction occurred at a price near the 52-week high of $34.36, with the stock having surged +85.1% over the prior 30 days and +60.4% over 90 days. His single prior sale at UMAC on 2025-12-12 showed poor timing: the stock rose +114.7% in the 90 days following that sale, indicating he sold before a substantial rally. The company is operationally profitable at the quarterly level ($10.3M net income) but was unprofitable on a full-year basis, creating ambiguity about underlying financial momentum. The current price of $26.39 is -23.2% from the 52-week high, suggesting the stock's recent gains have moderated since this transaction.

CFO Brian Joseph Hoff sells 150.0K shares of UMAC at $17.71 for $2.7M under pre-arranged 10b5-1 plan

CFO Brian Joseph Hoff sold 150,000 shares at $17.71 under a scheduled 10b5-1 trading plan on 2026-05-27, reducing his holdings by 29.8% from 502,650 to 352,650 shares. The sale occurs as the stock trades at $29.60 currently, representing a -7.5% discount from the 52-week high of $32.00, while the company reports the most recent quarter revenue of $8,095,836.00 and net income of $10,282,994.00, though full-year net income was negative. His prior sell at this ticker on 2025-12-12 posted 90-day returns of +114.8%, while his cross-ticker track record shows average 90-day returns of +114.8% after sells. Because this transaction is scheduled under a pre-arranged plan rather than discretionary, the sale execution timing itself carries no interpretive weight as a market signal.

CFO Brian Joseph Hoff sold 75,000 UMAC shares at $10.31; stock now $9.09, down 52.9% from 52-week high of $19.31

CFO Brian Joseph Hoff sold 75,000 shares (75.0K shares) of Unusual Machines at $10.31 on 2025-12-12, reducing his holdings by 15.3% to 415,475 shares (415.5K shares). The transaction occurred at a price notably above the current price of $9.09 and in a context where the stock has declined 52.9% from its 52-week high of $19.31 and dropped 21.9% over the past 90 days. Notably, this sale happens at a moment when the company's recent quarter showed net income of $1,603,465.00, yet the company was unprofitable over its most recent full fiscal year—signaling potential earnings volatility or sustainability concerns that may not be fully reflected in current market pricing. The sale size and timing relative to the company's profitability trajectory warrant investor scrutiny into whether this represents a broader concern about forward earnings or simply a liquidity event by a major shareholder.

COO Camden Andrew Ross sold 50,000 shares (50.0K) of UMAC at $10.32, reducing stake by 16.3% to 256,000 shares.

Camden Andrew Ross, the Chief Operating Officer, sold 50,000 shares (50.0K shares) on 2025-12-12 at $10.32, a sale that reduced his holdings by 16.3% from 306,000 to 256,000 shares. The stock currently trades at $9.09, down 52.9% from its 52-week high of $19.31 and down 21.9% over the past 90 days, indicating significant downward momentum. Most notably, the company was unprofitable over its most recent full fiscal year despite reporting a net income of $1,603,465.00 in the latest quarter, suggesting operational volatility or seasonal results that mask underlying challenges. The transaction price of $10.32 sits above the current $9.09, meaning the sale occurred before the stock's recent further decline, though still well below the 52-week high the stock had previously reached.

Director Robert Paul Lowry buys 32,895 shares of UMAC at $1.52; cluster pattern with 2 other insiders buying in past 14 days.

Director Robert Paul Lowry purchased 32,895 shares at $1.52 on 2024-10-30, increasing his holdings by 81.0% from 40,607 to 73,502 shares, with a total transaction value of $50,000.40. This activity occurs within a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated or coincident confidence among multiple directors at the company level. The stock currently trades at $1.87, representing a 22.2% gain since the purchase date. However, the company remains unprofitable with full-year net income of $-1,612,238.00 and latest quarterly revenue of only $1,411,124.00, against a market cap of $11,565,918.21, warranting close monitoring of whether insider accumulation reflects private information or market sentiment at a micro-cap in turnaround mode.

Director Rich Sanford bought 65,789 shares of UMAC at $1.52 on 2024-10-30 (total $100.0K), cluster buy activity amid unprofitable fundamentals.

Rich Sanford, a Director, purchased 65,789 shares at $1.52 totaling $100.0K on 2024-10-30, increasing his holdings by 124.3% to 118,696 shares. The purchase occurs as part of a cluster pattern: 2 other insiders also bought within the past 14 days. However, the fundamental backdrop is weak—the company posted quarterly revenue of $1,411,124.00 against net income of $-1,612,238.00, and was unprofitable over its most recent full fiscal year. Sanford's own cross-ticker track record shows an average 30-day return of -18.6% on 2 prior buys, and his two prior trades at UMAC (2024-08-26 and 2024-08-27) each saw -18.6% 30-day declines. The current stock price of $1.87 is -46.6% from the 52-week high, providing a lower valuation context for the purchase, though the stock has gained 22.2% over the prior 30 days.

Director Rich Sanford purchases 2,300 shares at $1.77–$1.80 avg at unprofitable UMAC; stock down 51.4% from 52-week high.

Rich Sanford (Director) executed two separate purchases totaling 2,300 shares for $4,075.00 between August 26–27, 2024, at a blended average price of $1.77, increasing his holdings by 5.3% to 45,435 shares. The company is unprofitable (net income of $-1.6M in the latest quarter and full-year net income was negative) and trades at $1.70, down 51.4% from its 52-week high of $3.50. The purchases occurred during a sharp recent decline (30-day change: -8.6%), though the stock has gained 25.9% over 90 days. The transaction volume and position size are modest relative to Sanford's existing stake, and no prior track record or execution context is available to assess whether this represents a shift in insider positioning.